BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, May 4, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 8, 2013
View Archived Issues
Tankyrase and/or Wnt signaling inhibitors designed at Novartis
Read More
Genetically engineered mouse model of pancreatic cancer developed
Read More
Shionogi reviews highlights of third quarter of fiscal 2012
Read More
Santen Pharmaceutical presents novel PARP inhibitors for ocular disorders
Read More
Microbiotix presents novel agents for bacterial infections
Read More
Eli Lilly patents new agents for sleep disorders
Read More
Mouse model allows testing of therapies targeting the human HTT gene
Read More
European decentralized registration procedure completed for BLI-800
Read More
ProtAffin Biotechnologie prepares new mutant polypeptides for cancer
Read More
Transgene divulges new mutant HBV polypeptides
Read More
Researchers at Glenmark Pharmaceuticals disclose novel monoclonal antibodies
Read More
New cholera vaccines presented by researchers in the U.S. and Bangladesh
Read More
Apocept receives FDA orphan drug designation and enters phase I study
Read More
Cerium oxide nanoparticles reduce ovarian cancer tumor growth in mice
Read More
Transgenic medaka model developed for screening drugs targeting oncogenes
Read More
Omeros reports toxicology study data for MASP-2 inhibitor
Read More
Bristol-Myers Squibb decides to stop development of analgesic
Read More
Eli Lilly discontinues clinical trials of tabalumab in RA
Read More
EMA grants accelerated assessment to trametinib application
Read More
Pergamum and Cadila Pharmaceuticals enter strategic collaboration
Read More
MSDC receives award from The Michael J. Fox Foundation
Read More
biOasis' Transcend-Herceptin conjugate shows promising antitumor activity
Read More
Dyax and CVie Therapeutics sign agreement for Kalbitor
Read More
Venaxis signs agreement with EMELCA Bioscience for E.U. launch of novel appendicitis test APPY1
Read More
Avexxin cleared to conduct study of AVX-001 in Denmark
Read More